Published in Vaccine Weekly, February 18th, 2004
The clinic on January 19, 2004, announced the investment by ExOxEmis of Little Rock, Ark.
"The development of such tests will help physicians determine more quickly and accurately the diagnosis of patients with inflammatory diseases, such as asthma...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.